Teleflex Incorporated (NYSE:TFX) Shares Sold by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. lessened its stake in Teleflex Incorporated (NYSE:TFX) by 7.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,313 shares of the medical technology company’s stock after selling 783 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Teleflex were worth $1,835,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Cromwell Holdings LLC increased its position in shares of Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after acquiring an additional 49 shares during the period. Apollon Wealth Management LLC increased its position in shares of Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after purchasing an additional 55 shares during the last quarter. SRS Capital Advisors Inc. raised its holdings in shares of Teleflex by 0.3% in the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after purchasing an additional 60 shares in the last quarter. Janney Montgomery Scott LLC lifted its position in shares of Teleflex by 0.4% during the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock worth $3,792,000 after purchasing an additional 65 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. increased its holdings in Teleflex by 4.5% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after buying an additional 66 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on TFX shares. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Truist Financial dropped their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Mizuho reduced their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Royal Bank of Canada dropped their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Trading Down 1.4 %

Shares of Teleflex stock opened at $173.61 on Friday. The company’s fifty day moving average is $180.84 and its two-hundred day moving average is $211.88. Teleflex Incorporated has a 1 year low of $171.69 and a 1 year high of $256.85. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The company has a market capitalization of $8.06 billion, a P/E ratio of 34.51, a PEG ratio of 1.78 and a beta of 1.16.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.